Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,240,722,841
-
Number of holders
-
1549
-
Total 13F shares, excl. options
-
1,199,337,377
-
Shares change
-
-35,549,043
-
Total reported value, excl. options
-
$140,402,300,771
-
Value change
-
-$4,005,236,404
-
Put/Call ratio
-
1.78%
-
Number of buys
-
764
-
Number of sells
-
-668
-
Price
-
$117.08
Significant Holders of GILEAD SCIENCES, INC. - Common Stock (GILD) as of Q2 2015
1,697 filings reported holding GILD - GILEAD SCIENCES, INC. - Common Stock as of Q2 2015.
GILEAD SCIENCES, INC. - Common Stock (GILD) has 1,549 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,199,337,377 shares
of 1,240,722,841 outstanding shares and own 96.66% of the company stock.
Largest 10 shareholders include Capital Research Global Investors (99,991,520 shares), FMR LLC (86,523,108 shares), VANGUARD GROUP INC (83,830,001 shares), STATE STREET CORP (59,037,579 shares), PRICE T ROWE ASSOCIATES INC /MD/ (43,313,403 shares), BlackRock Institutional Trust Company, N.A. (38,864,047 shares), Bank of New York Mellon Corp (28,122,391 shares), JPMORGAN CHASE & CO (26,581,315 shares), BlackRock Fund Advisors (24,180,338 shares), and Temasek Holdings (Private) Ltd (20,771,947 shares).
This table shows the top 1549 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.